Search results
Results from the WOW.Com Content Network
Sleisenger and Fordtran's Gastrointestinal and Liver Disease is a textbook on hepatology and gastroenterology for medical students, internists, and surgeons. [1] First published in 1978, it has undergone many revisions to reflect the rapid advances in internal medicine and is currently in its 11th edition.
A bland diet allows the digestive tract to heal before introducing foods that are more difficult to digest. A bland diet is designed primarily to help patients recover from gastrointestinal conditions or other medical circumstances in which improved digestion would be essential. [2] It is not especially effective as a long-term weight loss diet ...
For people with NASH and end-stage liver disease, liver failure, or liver cancer, liver transplantation is an accepted procedure according to the EASL. [16] People with NASH cirrhosis NASH who are being considered for a liver transplant warrant systematic evaluation for cardiovascular diseases (whether the symptoms are apparent or not). [5]
Arvinder Singh Soin was born in Birmingham, United Kingdom in the year 1963. He studied medicine and surgery in India and the UK. He attended All India Institute of Medical Sciences, New Delhi, where for 11 years obtaining MBBS and MS degrees.
In January 1994 he was diagnosed with liver cancer and cirrhosis, and given only a few months to live. [208] In March he received a liver transplant; he drank whisky on the way to the hospital, and arrived inebriated, but the operation went ahead. [209] He died of septicaemia on 30 January 1995. [210]
At 5 years post-transplant, 80% of lung transplants, 60% of heart transplants and 50% of kidney transplants are affected, while liver transplants are only affected 10% of the time. [20] Therefore, chronic rejection explains long-term morbidity in most lung-transplant recipients, [ 23 ] [ 24 ] the median survival roughly 4.7 years, about half ...
Liver allografts for transplant usually come from donors who have died from fatal brain injury. Living donor liver transplantation is a technique in which a portion of a living person's liver is removed (hepatectomy) and used to replace the entire liver of the recipient. This was first performed in 1989 for pediatric liver transplantation.
Mainly, the condition is treated by medical management, such as diet adjustment and usage of diuretics. When the condition does not respond, it is known as refractory hepatic hydrothorax: treatment includes inserting a transjugular intrahepatic portosystemic shunt (TIPS). The only curative treatment is a liver transplant. The prognosis is ...